PMID- 23050672 OWN - NLM STAT- MEDLINE DCOM- 20140310 LR - 20161125 IS - 1448-5990 (Electronic) IS - 1031-3613 (Linking) VI - 25 IP - 7 DP - 2013 TI - Differential expression of the P2X7 receptor in ovarian surface epithelium during the oestrous cycle in the mouse. PG - 971-84 LID - 10.1071/RD12196 [doi] AB - Purinergic signalling has been proposed as an intraovarian regulatory mechanism. Of the receptors responsible for purinergic transmission, the P2X7 receptor is an ATP-gated cationic channel that displays a broad spectrum of cellular functions ranging from apoptosis to cell proliferation and tumourigenesis. In the present study, we investigated the functional expression of P2X7 receptors in ovarian surface epithelium (OSE). P2X7 protein was detected in the OSE layer of the mouse, both in situ and in primary cultures. In cultures, 2'(3')-O-(4-Benzoylbenzoyl)adenosine-5'-triphosphate (BzATP) activation of P2X7 receptors increased [Ca(2+)]i and induced apoptosis. The functionality of the P2X7 receptor was investigated in situ by intrabursal injection of BzATP on each day of the oestrous cycle and evaluation of apoptosis 24h using the terminal deoxyribonucleotidyl transferase-mediated dUTP-fluorescein nick end-labelling (TUNEL) assay. Maximum effects of BzATP were observed during pro-oestrus, with the effects being blocked by A438079, a specific P2X7 receptor antagonist. Immunofluorescence staining for P2X7 protein revealed more robust expression during pro-oestrus and in OSE regions behind the antral follicles, strongly supporting the notion that the differences in apoptosis can be explained by increased receptor expression, which is regulated during the oestrous cycle. Finally, P2X7 receptor expression was detected in the OSE layer of human ovaries, with receptor expression maintained in human ovaries diagnosed with cancer, as well as in the human ovarian carcinoma SKOV3 cell line. FAU - Vazquez-Cuevas, F G AU - Vazquez-Cuevas FG AD - Departamento de Neurobiologia Celular y Molecular, Instituto de Neurobiologia, Universidad Nacional Autonoma de Mexico, Boulevard Juriquilla 3001, Juriquilla Queretaro, CP, 76230, Queretaro Mexico. FAU - Cruz-Rico, A AU - Cruz-Rico A FAU - Garay, E AU - Garay E FAU - Garcia-Carranca, A AU - Garcia-Carranca A FAU - Perez-Montiel, D AU - Perez-Montiel D FAU - Juarez, B AU - Juarez B FAU - Arellano, R O AU - Arellano RO LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Australia TA - Reprod Fertil Dev JT - Reproduction, fertility, and development JID - 8907465 RN - 0 (3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methylpyridine) RN - 0 (Purinergic P2X Receptor Agonists) RN - 0 (Purinergic P2X Receptor Antagonists) RN - 0 (Pyridines) RN - 0 (Receptors, Purinergic P2X7) RN - 0 (Tetrazoles) RN - 4P5DXU1F8Q (3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate) RN - 8L70Q75FXE (Adenosine Triphosphate) RN - SY7Q814VUP (Calcium) SB - IM MH - Adenosine Triphosphate/analogs & derivatives/pharmacology MH - Animals MH - Apoptosis/drug effects MH - Calcium/metabolism MH - Cell Line, Tumor MH - Cells, Cultured MH - Epithelium/chemistry/physiology MH - Estrous Cycle/*physiology MH - Female MH - Humans MH - In Situ Nick-End Labeling MH - Mice MH - Ovarian Neoplasms/chemistry MH - Ovary/*chemistry/physiology MH - Purinergic P2X Receptor Agonists/pharmacology MH - Purinergic P2X Receptor Antagonists/pharmacology MH - Pyridines/pharmacology MH - Receptors, Purinergic P2X7/*analysis/drug effects/*physiology MH - Tetrazoles/pharmacology EDAT- 2012/10/12 06:00 MHDA- 2014/03/13 06:00 CRDT- 2012/10/12 06:00 PHST- 2012/06/21 00:00 [received] PHST- 2012/09/04 00:00 [accepted] PHST- 2012/10/12 06:00 [entrez] PHST- 2012/10/12 06:00 [pubmed] PHST- 2014/03/13 06:00 [medline] AID - RD12196 [pii] AID - 10.1071/RD12196 [doi] PST - ppublish SO - Reprod Fertil Dev. 2013;25(7):971-84. doi: 10.1071/RD12196.